The best and worst funds of Q1
1 Apr 15
Although 2015 has been touted as the year of the stock picker, it would seem from the performance rankings that much of the success in the first quarter has been heavily influenced by geography and large macro swings.
Polar Capital Biotechnology Fund
David Pinniger has been the manager of the Polar Capital Biotechnology Fund since 2013 after joining the firm from SV Life Sciences International Biotechnology Trust.
Over the three months, it returned 22.3%. Over one year it has risen 62.95%.

